Stefon Diggs
Story Poster
30:30
Reed Between The Lines: Shemar Stewart striving for greatness
1 mo ago by Ar'maj Reed-Adams
With Texas A&M's Pro Day set for Thursday, NFL Combine darling and potential first-rounder Shemar Stewart joined Ar'maj Reed-Adams on the second episode of Reed Between The Lines. Stewart spoke about his upbringing, preparing for the 2025 NFL Draft and much more.
Story Poster
21:28
John Harris shines light on Christian Kirk's addition to the Texans
1 mo ago by David Nuño
A couple of weeks ago, the Houston Texans acquired former Texas A&M receiver Christian Kirk via a trade with the Jacksonville Jaguars. On Wednesday, Texans sideline reporter John Harris joined TexAgs Live to explain what Houston gains by adding Kirk and more.
Story Poster
8:49
ProFootballTalk's Charean Williams makes her Super Bowl prediction
2 mo ago by David Nuño
Charean Williams of ProFootballTalk.com joined Tuesday's edition of TexAgs Live to share her Super Bowl predictions. She also helped us make sense of Brown's DE Myles Garrett's trade request, the Dallas Maverick's shocking Luka Doncic trade and more.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
10:03
Charean Williams offers thoughts on the Cowboys' future at head coach
3 mo ago by David Nuño
ProFootballTalk.com writer Charean Williams joined TexAgs Live to detail the conversations surrounding the NFL and the Dallas Cowboys. After Mike McCarthy and Jerry Jones could not agree on a deal, Charean discusses what could be the next move in Dallas.
Story Poster
13:05
Charean Williams offers her thoughts on Texas A&M's QB situation
5 mo ago by David Nuño
Both Conner Weigman and Marcel Reed have had their time in the spotlight against top-10 teams this fall. On Tuesday, ProFootballTalk's Charean Williams spoke about what she would do at the all-important position as No. 10 Texas A&M travels to South Carolina this week.
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.